Did a Russian oligarch's fall take down Biopure successor OPK Biotech?

A group of creditors are looking to force OPK Biotech, the holding company created by a former Russian oligarch to buy out defunct Biopure's assets, into its own bankruptcy proceeding.

Creditors hoping to collect $1.4 billion from OPK Biotech are seeking to force the Biopure Corp. successor into Chapter 7 bankruptcy.

Biopure, OPK Biotech

News Well, Bankruptcy, Biotech , Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1o4Rz1e